Top Markets
#1 MowCat MowCat +48.90%
#2 Bermuda Shorts Bermuda Shorts +35.34%
#3 aPriori aPriori +23.54%
#4 Derive Derive +19.95%
#5 Velvet Velvet +19.35%
#6 Biconomy Biconomy +19.15%
#7 Audiera Audiera +17.60%
#8 Quack AI Quack AI +17.21%
#9 Perle Perle +13.71%
#10 Block Street Block Street +11.88%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Classement en actions #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Prix de l'action
$3.45
Dernière synchronisation: 2021-09-21
Capitalisation boursière
$4.29M
Changement (1 jour)
2.07%
Changement (1 an)
0.00%
Pays
US
Échange AzurRx BioPharma, Inc. (AZRX)

Catégorie

Healthcare
Historique du prix de l'action pour AzurRx BioPharma, Inc. (AZRX)
Prix de clôture le plus élevé : $5.04 le 2021-09-01

Prix de clôture le plus bas : $50.52 le 2016-10-01
Historique du prix de l'action de AzurRx BioPharma, Inc. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE